Viemed Healthcare, Inc.
NASDAQ:VMDMedical - Devices
+$0.07 today
- Market cap
- $332.70M
- Beta
- 1.13
- P/E (TTM)
- 27.4
- EPS (TTM)
- $0.39
Volume 0.26M
Average 0.26M
VMD Total Current Liabilities
All obligations due within one year.
Viemed Healthcare, Inc.NASDAQ: VMD
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities rises 14.7% from a year ago
Total current liabilities stood at $40.71M at the end of Q1 FY2026, up 14.7% from a year earlier and down 0.9% from the prior quarter. Over 3 fiscal years it compounded at +29.6% a year.
Context
- Total current liabilities amounted to 20.6% of total assets at the end of Q1 FY2026, up 0.7 pp from a year earlier.
- Total current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +14.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 41.06M USD
- Year-over-year change
- +10.0%
- 4-year CAGR
- +23.2%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 41.06M | +10.0% |
| FY2024 | 2024-12-31 | 37.33M | +16.2% |
| FY2023 | 2023-12-31 | 32.12M | +70.3% |
| FY2022 | 2022-12-31 | 18.86M | +5.9% |
| FY2021 | 2021-12-31 | 17.81M | — |
Total Current Liabilities vs competitors
How VMD compares with its peers on the latest reported figures
- VMD's Mar 2026 total current liabilities of $40.71M is the 3rd highest of the 11 companies compared; the peer median is $22.31M.
- Its year-over-year change of +14.7% is the 7th highest of 11, against a peer median of +20.5%.
- Total current liabilities amounts to 20.6% of total assets for VMD, versus a peer median of 16.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $61.45M | -6.1% | -0.9% | 21.5% | |
| Mar 2026 | $49.91M | +23.5% | +33.6% | 13.6% | |
| Mar 2026 | $40.71M | +14.7% | +29.6% | 20.6% | |
| Mar 2026 | $39.66M | +102.8% | +21.0% | 21.2% | |
| Mar 2026 | $37.61M | +9.9% | -10.2% | 15.1% | |
| Mar 2026 | $26.33M | +131.2% | -8.2% | 25.6% | |
| Mar 2026 | $18.3M | -61.3% | -33.3% | 49.3% | |
| Mar 2026 | $18.16M | +49.8% | -14.8% | 16.6% | |
| Dec 2025 | $16.89M | +20.9% | -12.3% | 10.4% | |
| Mar 2026 | $10.23M | +20.2% | +13.5% | 17.2% | |
| Mar 2026 | $9.49M | +11.5% | +18.1% | 9.5% | |
| Peer median (excluding VMD) | $22.31M | +20.5% | -4.6% | 16.9% | |
Competitors are the stored peer set for VMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 28.41M | 16.91M | 12.84M | 17.54M | 13.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 14.72M | 15.41M | 18.45M | 24.91M | 25.59M |
| Inventory | 2.46M | 3.57M | 4.63M | 4.32M | 5.05M |
| Other Current Assets | 0 | 3.85M | 2.45M | 6.11M | 4.36M |
| Total Current Assets | 47.31M | 39.74M | 38.37M | 52.88M | 48.49M |
| Property, Plant & Equipment (Net) | 62.85M | 68.44M | 76.85M | 79.16M | 82.36M |
| Goodwill | 0 | 0 | 29.77M | 32.99M | 58.94M |
| Intangible Assets | 0 | 0 | 567K | 848K | 1.29M |
| Long-term Investments | 2.16M | 4.16M | 3.9M | 2.79M | 2.79M |
| Tax Assets | 4.79M | 3.12M | 4.56M | 8.4M | 5.29M |
| Other Non-current Assets | 862K | 1.59M | 887K | 0 | 15.79M |
| Total Non-current Assets | 70.65M | 77.3M | 116.53M | 124.19M | 166.45M |
| Total Assets | 117.96M | 117.04M | 154.9M | 177.07M | 214.94M |
| Account Payables | 5.25M | 4.9M | 7.41M | 9.34M | 12.33M |
| Short-term Debt | 1.48M | 0 | 1.07M | 409K | 1.09M |
| Tax Payables | 0 | 0 | 2.15M | 3.88M | 0 |
| Deferred Revenue | 3.75M | 4.62M | 6.21M | 6.69M | 7.52M |
| Other Current Liabilities | 2.34M | 3.19M | 6.52M | 5.1M | 6.3M |
| Total Current Liabilities | 17.81M | 18.86M | 32.12M | 37.33M | 41.06M |
| Long-term Debt | 4.31M | 0 | 6M | 3.59M | 11.29M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 15.79M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 757K | 889K | 558K | 846K | 922K |
| Total Non-current Liabilities | 5.33M | 1.09M | 8.88M | 6.44M | 30.37M |
| Total Liabilities | 23.14M | 19.95M | 41M | 43.77M | 71.42M |
| Common Stock | 14.01M | 15.12M | 18.7M | 23.37M | 16.91M |
| Retained Earnings | 73.34M | 69.85M | 79.5M | 89.69M | 102.89M |
| Accumulated OCI | (278K) | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 1.91M | 1.98M |
| Total Equity | 94.82M | 97.09M | 113.9M | 133.3M | 143.52M |
| Total Debt | 6.52M | 694K | 10.32M | 6.87M | 15.95M |
| Net Debt | (21.89M) | (16.22M) | (2.52M) | (10.67M) | 2.45M |
Viemed Healthcare, Inc.
NASDAQ:VMD
Intrinsic Alpha fair value
Locked
Current Price
$8.78
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.